An interventional study of Adipeau face cream in Atrophy, Hemifacial, Elastosis and Photoaging, sponsored by Adipeau Inc.. Completed at 1 site in United States. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-11.
Sponsored by Adipeau Inc. · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 29 studies in Atrophy with a site in United States — 6 open to participants now, 8 under way, 1 of them phase 3. Atrophy · United States.
Among the 29 studies in Atrophy with a site in United States, this one is the 14th largest by enrollment of the 24 interventional ones that give a count, is the only one that started in 2021, is one of 14 with no phase, and was the 20th registered.
126 studies on the registry are indexed under Atrophy; 21 are open to participants now.
Browse Atrophy studies →6 of the 29 studies in Atrophy with a site in United States are open now. Recruiting first, the newest first:
Kalpna Kay Durairaj, MD, FACS · Sites in United States
Ages 21–65
Hebrew SeniorLife · Sites in United States, Israel
Ages 65–90
Carl Zeiss Meditec-Dublin CoCe · Sites in United States
Ages 18+ · Healthy volunteers
University of Kansas Medical Center · Sites in United States
Ages 18–45 · Women only
University of Oregon · Sites in United States
Ages 18–80 · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 13 Atrophy studies recruiting now, 5 (38%) set no upper age limit and 4 (31%) stop at 75 or younger; none take children under 18; 5 take healthy volunteers.
This study: 18 Years to 75 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
29 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 1 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 35 is close to the median of 36 across 105 interventional studies indexed under Atrophy.
Median enrollment 42 across the 24 interventional studies, 13 across the 5 observational. Of the 19 that completed or were terminated, 4 (21%) have results posted.
This tab as a report to print or save as PDF → With an account.
11 of 29 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Adipeau Inc. as lead sponsor.
Adipeau Inc. has 1 study filed under Atrophy — fewer than ten, so there is no comparison to draw.
2 of the studies in Atrophy with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05926219University of OregonC-Protein in Fatigue and Aging | 2027-01 |
| NCT07419854Kalpna Kay Durairaj, MD, FACSRestoring Facial Volume After GLP-1 Weight Loss With Radiesse | 2027-08 |
Add all 2 to your calendar (.ics) → With an account.
Among the 29 studies in Atrophy with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
A Clinical Trial Evaluating Efficacy of a Skin Cream Targeting Dermal Fat in Improving the Skin Elasticity of Healthy Volunteers.
This is a single-arm study with subjects serving as their own controls. The study evaluates a face cream comprised of natural agents with adipogenic and lipolytic activities. The combination of adipogenic and lipolytic impulses is theorized to be more effective in promoting regeneration and healthy cell size in the dermal white adipose tissue than other approaches (e.g., adipogenic + lipogenic or anti-adipogenic + lipolytic). The health of the dermal white adipose tissue is reflected by the strength and elasticity of the skin and the distribution of volume in the face.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
-
Exclusion Criteria:
Cosmetic cream
Other: Adipeau face cream
Adipeau face cream contains the natural actives Carthamus Tinctorius (Safflower) Seed Oil and Kaempferia Parviflora Rhizome Extract (Black Ginger).
Change in Skin Elasticity
Elasticity measured by DermaLab Skin Elasticity Meter.
Time frame: Six months and 12 months..
Change in Skin Volume
Increases and decreases measured by Cherry Imaging 3D Scanning System.
Time frame: Six months and 12 Months.
FaceQ skin satisfaction surveys
Satisfaction With Skin, Appraisal of Lower Eyelids, Satisfaction with Cheeks, Adverse Effects
Time frame: Two, Six and 12 Months.
Plan to share: No
Ran from Jan 2021 to primary completion in Apr 2022, 14 months.
Of 49 interventional studies with no phase under Atrophy, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 37. This study's 14 months is close to that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.